CRTX: Summary for Cornerstone Therapeutics Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 6:39am EST - Canadian Markets open in 2 hours and 51 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Cornerstone Therapeutics Inc. (CRTX)

On Feb 9: 5.01 USD 0.00 (0.00%)

MORE ON CRTX

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Cornerstone Therapeutics Inc. (NCM:CRTX) Delayed quote data

Last Trade:	5.01 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	5.01
Open:	N/A
Bid:	N/A
Ask:	5.79 x 100
1y Target Est:	10.50

Day's Range:	N/A - N/A
52wk Range:	2.73 - 12.29
Volume:	0
Avg Vol (3m):	49,877.8
Market Cap:	125.82M
P/E (ttm):	7.19
EPS (ttm):	0.70
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add CRTX to Portfolio

Download Data

HEADLINES

•	Cornerstone Provides Guidance
	Zacks.com (Mon, Jan 11)

•	Cornerstone Therapeutics gives 2010 forecasts
	AP (Thu, Jan 7)

•	Cornerstone Therapeutics Provides 2010 Financial Guidance
	PRNewswire (Thu, Jan 7)

•	7 Stocks Attracting Top Investors
	at Motley Fool (Wed, Jan 6)

•	5 Top Stocks at Half Price
	at Motley Fool (Tue, Dec 22)

•	Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
	PRNewswire (Fri, Dec 18)

•	Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference
	PRNewswire (Mon, Nov 23)

•	Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
	PRNewswire (Fri, Nov 20)

•	Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
	PRNewswire (Mon, Nov 16)

•	CORNERSTONE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Fri, Nov 13)

•	Cornerstone Therapeutics Appoints General Counsel
	PRNewswire (Fri, Nov 13)

More Headlines for CRTX...

ANALYST

EPS Est (next year) (Dec-09) :	0.34
EPS Est (in 2 years) (Dec-10) :	0.01
Avg Rec (current)*:	1.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Cornerstone Therapeutics Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for the respiratory market in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•